Tearsheet

Key Takeaways

  • XBI has returned +30.4% YTD vs +11.0% for SPY; +80.6% over the past 12 months (SPY +21.7%). details →
  • Priced in gold, XBI has returned -10.5% over the past 3 years, vs +90.7% in dollars — its dollar gains have lagged gold. details →
  • Over the past month, XBI has seen net inflows of +$967M (+9.5% of assets). details →
  • Only 31% of XBI's portfolio (by weight) is currently profitable, vs 98% for SPY. details →
  • XBI's top 10 holdings represent 13% of the fund vs 37% for SPY — a more diversified portfolio. details →
Last updated: 7/10/2026.

Price Chart

Asset Allocation with XBI

Risk Tolerance:
ConservativeModerateAggressive
Moderate — 55% equity / 25% bonds / 20% alternatives
10Y Return (ann.)
+10.4%
Volatility
16.3%
Sharpe
0.52
YTD
+17.4%
Modeled with monthly rebalancing to target weights; 10-year figures are annualized from monthly returns. Illustrative only — past performance is not indicative of future results.

Learn More →
Tailored Asset Allocation
[1] Personalized 5 Level Risk Tolerance Assessment
[2] Asset Allocation for My Risk Tolerance
Learn More →
Protect Wealth
[1] Defensive Portfolios
[2] Tax-Efficient Strategies

Valuation & Yield

 Forward [4,5]NowHistorical (CYE & TTM)
 7/31/277/11/2620252024202320222021
Share Price CYE $159.03$121.93$89.72$88.83$82.56$111.36
Dividend/Share TTM $0.43$0.45$0.13$0.02$0.00$0.04

Valuation [1]
       
P/S7.168.466.667.167.754.5818.18
P/E 66.6040.5936.8883.9170.7591.26
P/E (Non-GAAP) [2]47.3857.4541.4033.4582.2955.6767.22
P/FCF 

Yields TTM
       
Earnings Yield2.11%1.50%2.46%2.71%1.19%1.41%1.10%
Dividend Yield0.27%0.27%0.37%0.15%0.02%0.00%0.04%
Total Yield (TY)2.38%1.77%2.83%2.86%1.21%1.41%1.13%

Risk Premium [3]
       
Risk Free Rate (Rf)4.54%4.54%4.18%4.58%3.88%3.88%1.52%
Risk Prem. (TY - Rf)-2.16%-2.77%-1.35%-1.72%-2.67%-2.47%-0.39%

Growth Rates [6]
       
Sales Growth18.3%-2.7%23.9%13.7%-11.0%5.3% 
Earnings Growth [7]       

[1] P/E uses the aggregate method over profitable constituents; P/FCF aggregates net free cash flow across all constituents (negative-FCF names reduce it); P/S uses all constituents. Ratios reflect current ETF holdings at current weights. P/FCF has no Forward column (no analyst FCF estimate).
[2] P/E (Non-GAAP) uses analyst consensus net income (adjusted basis) for all periods. The standard P/E row above uses GAAP net income.
[3] The premium above the risk free rate (US 10Y) offered by the investment. Negative premiums can indicate stretched valuations.
Show more
[4] Forward P/S and Forward P/E determined as:
  (a) Aggregate using constituent analyst consensus. FY1/FY2 blended by months of overlap to the 12-month window ending 7/31/27.
  (b) Uses current weights and market caps. Shown only when ≥90% of weight has estimates.
[5] Forward dividend yield and risk-free rate are carried at current, not projected.
[6] Growth Rates:
  (a) Weighted by current constituent weights. Shown when ≥90% of weight is covered.
  (b) Now and Historical columns show realized year-over-year change.
  (c) Forward growth rates using next fiscal year (FY2) vs. current fiscal year (FY1) consensus. This differs from the blended target date used for calculating Forward P/S and P/E.
[7] Earnings Growth reflects:
  (a) Non-GAAP earnings growth for forward earnings using next fiscal year (FY2) vs. current fiscal year (FY1) consensus.
  (b) GAAP earnings growth for Now and Historical growth rates.

Highlights
YIELD
XBI's earnings yield is 1.50%, based on its 66.6x trailing P/E. With a 0.27% dividend yield, XBI is yielding 1.77% in total.
RISK
Compared to US Treasuries at 4.54%, XBI's total yield implies a -2.77% risk premium. A negative risk premium means investors earn less than risk-free Treasuries — valuations are historically stretched, though expectations of falling interest rates or fast earnings growth can justify such levels.
FORWARD EXPECTATIONS
Based on analyst estimates, XBI's forward total yield is 2.38%, implying a -2.16% risk premium assuming stable Treasury rates.

Top 20 Holdings for XBI

Total Weights
Top 5: 7.1% | Top 10: 13.3% | Top 20: 25.0%

TickerHoldingETF WeightSales WeightEarnings WeightFwd P/SFwd P/EFwd Sales GrowthFwd Earnings Growth
Total68.85%100.00%100.00%7.247.4+18.3%+6.6%
Top 2013.67%9.71%0.00%12.5461.3+36.2%+823.0%
APGEApogee Therapeutics1.50%
MRNAModerna1.48%1.48%11.5+20.3%
TWSTTwist Bioscience1.41%1.27%11.0+17.0%
KYMRKymera Therapeutics1.37%0.07%193.0-49.0%
ORKAOruka Therapeutics1.37%
VKTXViking Therapeutics1.27%
ERASErasca1.26%
PRAXPraxis Precision Medicines1.25%
RVMDRevolution Medicines1.22%
CGONCG Oncology1.21%0.01%114.6+689.4%
RYTMRhythm Pharmaceuticals1.21%0.44%16.7+81.7%
MIRMMirum Pharmaceuticals1.20%1.17%9.5+20.5%
NTRANatera1.20%0.96%12.3+18.9%
CYTKCytokinetics1.19%0.15%37.9+251.4%
PCVXVaxcyte1.16%
ROIVRoivant Sciences1.16%0.00%99.5+659.6%
COGTCogent Biosciences1.15%
TVTXTravere Therapeutics1.13%1.43%6.138.1+38.9%+823.0%
SRRKScholar Rock1.12%
RAREUltragenyx Pharmaceutical1.12%2.71%3.9+32.7%
[1] Total and Top 20 rows are weighted aggregates across constituents.
[2] Forward P/S and P/E ratios use consensus sales and earnings for the 12 months ending 7/31/27. Individual constituent FY1 and FY2 consensus figures adjusted to align with 7/31/27.
[3] Forward Sales and Non-GAAP Earnings Growth are calculated as next fiscal year (FY2) consensus growth over current fiscal year (FY1) consensus. They are not derived from the forward P/S and P/E multiples shown.

Performance for XBI Top Holdings

TickerHoldingWeightMkt Price
7/10
1D Rtn1M RtnYTD Rtn1Y Rtn3Y Rtn5Y Rtn10Y Rtn
XBIState Street SPDR S&P Biotech ETF100.00%159.03-3.2%23.4%30.4%80.6%90.7%19.5%178.2%
APGEApogee Therapeutics1.50%133.650.1%61.6%77.1%246.5%   
MRNAModerna1.48%68.27-10.8%48.4%131.5%99.2%-44.1%-70.7% 
TWSTTwist Bioscience1.41%90.64-3.2%33.7%185.7%135.6%336.4%-29.4% 
KYMRKymera Therapeutics1.37%119.350.3%52.6%53.4%164.0%429.7%126.2% 
ORKAOruka Therapeutics1.37%86.79-1.7%35.5%186.3%516.8%556.0%265.4%-76.3%
VKTXViking Therapeutics1.27%38.86-5.5%40.0%10.5%24.2%142.9%529.8%2,889.2%
ERASErasca1.26%18.53-3.4%38.6%398.1%1,119.1%573.8%  
PRAXPraxis Precision Medicines1.25%324.99-2.4%35.0%10.3%546.1%1,566.6%11.0% 
RVMDRevolution Medicines1.22%186.88-2.2%29.6%134.6%385.4%591.4%470.3% 
CGONCG Oncology1.21%75.242.6%37.0%81.2%177.5%   
RYTMRhythm Pharmaceuticals1.21%108.40-6.1%26.5%1.3%21.7%571.2%445.3% 
MIRMMirum Pharmaceuticals1.20%122.13-4.4%29.9%54.6%130.4%359.0%647.0% 
NTRANatera1.20%269.95-4.2%24.7%17.8%65.2%450.9%123.2%2,025.6%
CYTKCytokinetics1.19%84.87-1.4%26.5%33.6%131.9%141.6%333.2%756.4%
PCVXVaxcyte1.16%58.21-2.7%28.2%26.2%60.6%24.9%159.8% 
ROIVRoivant Sciences1.16%35.97-2.3%26.6%65.8%210.9%224.3%263.3% 
COGTCogent Biosciences1.15%38.87-4.0%23.9%9.4%258.2%213.0%464.2% 
TVTXTravere Therapeutics1.13%56.59-3.2%21.1%48.1%241.9%272.1%281.3%204.7%
SRRKScholar Rock1.12%56.71-2.1%28.6%28.7%48.8%659.2%90.2% 
RAREUltragenyx Pharmaceutical1.12%33.82-2.3%47.2%47.0%9.0%-22.5%-63.0%-37.8%

Guidance Updates for XBI Top Holdings

 TickerCompanyEarnings DateGuidance MetricMidpoint Value% ChangeGuidance Change
TWST_5042026TWSTTwist Bioscience5/4/2026Q3 2026 Revenue114.50 Mil6.5%Higher NewNew Guidance Higher than Prior Actual of 107.50 Mil for Q2 2026

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
XBI Return-20%-26%8%1%36%35%17%
Peers Return33%-5%32%13%33%44%258%
S&P 500 Return27%-19%24%23%16%10%101%

Monthly Win Rates [3]
XBI Win Rate33%50%50%50%67%100% 
Peers Win Rate63%48%58%57%67%66% 
S&P 500 Win Rate75%42%67%75%67%57% 

Max Drawdowns [4]
XBI Max Drawdown-37%-46%-30%-20%-26%-10% 
Peers Max Drawdown-18%-35%-16%-18%-27%-15% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: SMH, SOXX, IBB, ITA, XOP.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 7/10/2026 (YTD)

Sharpe Ratios Compared

One measure of reward vs. risk is a Sharpe ratio. A higher ratio indicates better risk-adjusted returns. Most funds have Sharpe ratios < 1.0.

Ticker1Y3Y5Y
XBI2.420.780.15
Equity Top Results (3Y)   
NUSC2.472.472.47
IALT2.092.092.09
SPMO1.671.650.98
VLUE2.901.450.74
SMH2.401.410.98

Results as of 6302026.

How Low Can It Go

EventXBIS&P 500
2025 US Tariff Shock
  % Loss-24.6%-18.8%
  % Gain to Breakeven32.6%23.1%
  Time to Breakeven147 days79 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-22.9%-9.5%
  % Gain to Breakeven29.7%10.5%
  Time to Breakeven47 days24 days
2023 SVB Regional Banking Crisis
  % Loss-14.5%-6.7%
  % Gain to Breakeven17.0%7.1%
  Time to Breakeven48 days31 days
2022 Inflation Shock & Fed Tightening
  % Loss-45.6%-24.5%
  % Gain to Breakeven83.8%32.4%
  Time to Breakeven1290 days427 days
2020 COVID-19 Crash
  % Loss-32.9%-33.7%
  % Gain to Breakeven49.1%50.9%
  Time to Breakeven53 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-31.1%-19.2%
  % Gain to Breakeven45.0%23.8%
  Time to Breakeven351 days105 days

Compare to SMH, SOXX, IBB, ITA, XOP

In The Past

State Street SPDR S&P Biotech ETF's stock fell -24.6% during the 2025 US Tariff Shock. Such a loss loss requires a 32.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventXBIS&P 500
2025 US Tariff Shock
  % Loss-24.6%-18.8%
  % Gain to Breakeven32.6%23.1%
  Time to Breakeven147 days79 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-22.9%-9.5%
  % Gain to Breakeven29.7%10.5%
  Time to Breakeven47 days24 days
2022 Inflation Shock & Fed Tightening
  % Loss-45.6%-24.5%
  % Gain to Breakeven83.8%32.4%
  Time to Breakeven1290 days427 days
2020 COVID-19 Crash
  % Loss-32.9%-33.7%
  % Gain to Breakeven49.1%50.9%
  Time to Breakeven53 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-31.1%-19.2%
  % Gain to Breakeven45.0%23.8%
  Time to Breakeven351 days105 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-21.4%-3.7%
  % Gain to Breakeven27.2%3.9%
  Time to Breakeven11 days6 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-42.3%-12.2%
  % Gain to Breakeven73.2%13.9%
  Time to Breakeven497 days62 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-26.7%-17.9%
  % Gain to Breakeven36.5%21.8%
  Time to Breakeven172 days123 days
2008-2009 Global Financial Crisis
  % Loss-29.1%-53.4%
  % Gain to Breakeven41.0%114.4%
  Time to Breakeven371 days1085 days

Compare to SMH, SOXX, IBB, ITA, XOP

In The Past

State Street SPDR S&P Biotech ETF's stock fell -24.6% during the 2025 US Tariff Shock. Such a loss loss requires a 32.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

XBI Dip Buy History


Get Notified
Alerts when dip buy opportunities arise.
Notify Me →

Current Dip Buy Opportunities Across ETFs

ETFs currently down 5% or more from trailing 6M peaks.

TickerNameDip %Mkt PricePrice DatePeak PricePeak Date# Days
AKREAkre Focus ETF-16.4%55.14710202665.921112026180
SCHCSchwab International Small-Cap Equity ETF-6.3%48.30710202651.543012026131
IEMGiShares Core MSCI Emerging Markets ETF-5.4%81.32710202686.00622202618
EEMiShares MSCI Emerging Markets ETF-6.1%66.90710202671.21622202618
ASHRXtrackers Harvest CSI 300 China A-Shares ETF-5.1%35.38710202637.30622202618
EWYiShares MSCI South Korea ETF-16.3%183.527102026219.20621202619
EWZiShares MSCI Brazil ETF-13.9%35.93710202641.73414202687
FXIiShares China Large-Cap ETF-17.9%33.48710202640.781292026162
ILFiShares Latin America 40 ETF-9.4%34.51710202638.10414202687
KWEBKraneShares CSI China Internet ETF-30.0%26.38710202637.661122026179
MTUMiShares MSCI USA Momentum Factor ETF-6.8%321.777102026345.22622202618
URAGlobal X Uranium ETF-30.5%42.97710202661.811282026163
BOTZGlobal X Funds Global X Robotics & Artificial Intelligence ETF-11.3%36.91710202641.63513202658
ROBOROBO Global Robotics & Automation Index ETF-8.2%82.96710202690.34602202638
LITGlobal X Lithium & Battery Tech ETF-21.1%72.32710202691.62511202660
ICLNiShares Global Clean Energy ETF-18.9%19.25710202623.75602202638
ARKQARK Autonomous Technology & Robotics ETF-13.8%123.997102026143.82528202643
ARKXARK Space & Defense Innovation ETF-15.1%32.05710202637.74528202643
NASATema Space Innovators ETF-37.5%26.18710202641.89527202644
AGIXKraneShares Artificial Intelligence ETF-8.0%45.44710202649.40601202639
GDEWisdomTree Efficient Gold Plus Equity Strategy Fund-10.6%62.91710202670.39511202660
RAAXVanEck Real Assets ETF-7.6%39.47710202642.70511202660
VGTVanguard Information Technology ETF-6.0%118.087102026125.62602202638
XLKState Street Technology Select Sector SPDR ETF-6.3%185.787102026198.21602202638
XLEState Street Energy Select Sector SPDR ETF-12.0%55.08710202662.563292026103
XLCState Street Communication Services Select Sector SPDR ETF-6.7%111.647102026119.702012026159
XLYState Street Consumer Discretionary Select Sector SPDR ETF-5.7%117.247102026124.271122026179
XLPState Street Consumer Staples Select Sector SPDR ETF-6.0%84.12710202689.513012026131
IYMiShares U.S. Basic Materials ETF-5.7%178.247102026189.083022026130
FXNFirst Trust Energy AlphaDEX Fund-11.0%20.62710202623.183292026103
SMHVanEck Semiconductor ETF-8.7%611.037102026668.91622202618
SOXXiShares Semiconductor ETF-11.2%581.347102026655.01622202618
XOPState Street SPDR S&P Oil & Gas Exploration & Production ETF-15.7%158.577102026188.183292026103
IGViShares Expanded Tech-Software Sector ETF-14.2%92.417102026107.70601202639
MISLFirst Trust Indxx Aerospace & Defense ETF-12.6%44.53710202650.981192026172
RINGiShares MSCI Global Gold Miners ETF-34.7%64.89710202699.423012026131
SOXQInvesco PHLX Semiconductor ETF-11.3%102.067102026115.11622202618
BWXState Street SPDR Bloomberg International Treasury Bond ETF-5.7%21.59710202622.902162026144
IGOViShares International Treasury Bond ETF-5.0%40.84710202642.993012026131
TLTiShares 20+ Year Treasury Bond ETF-5.6%84.47710202689.483012026131
SPTLState Street SPDR Portfolio Long Term Treasury ETF-5.2%25.69710202627.093012026131
EDVVanguard World Funds Extended Duration ETF-7.7%62.25710202667.423012026131
PDBCInvesco Optimum Yield Diversified Commodity Strategy No K-1 ETF-13.1%16.44710202618.91512202659
DBCInvesco DB Commodity Index Tracking Fund-13.2%27.52710202631.69512202659
COMTiShares GSCI Commodity Dynamic Roll Strategy ETF-14.1%31.37710202636.53519202652
GSGiShares GSCI Commodity-5.8%30.01710202631.853182026114
BCIabrdn Bloomberg All Commodity Strategy K-1 Free ETF-11.3%22.99710202625.91512202659
FTGCFirst Trust Global Tactical Commodity Strategy Fund-8.2%28.02710202630.53512202659
HGERHarbor Commodity All-Weather Strategy ETF-8.7%30.57710202633.47512202659
GLDSPDR Gold Trust-24.0%377.017102026495.901292026162
IAUiShares Gold Trust-23.9%77.267102026101.571292026162
GLDMSPDR Gold MiniShares Trust-23.9%81.297102026106.771292026162
SGOLETFS Physical Swiss Gold Shares-13.1%44.66710202651.411292026162
BARDirexion Daily Gold Bull 3X Shares-16.6%44.34710202653.161292026162
SLViShares Silver Trust-48.9%53.957102026105.601282026163
SIVRETFS Physical Silver Shares Trust ETF-24.8%83.397102026110.871282026163
PPLTETFS Physical Platinum Shares-41.4%14.77710202625.231252026166
CPERUnited States Copper Index Fund ETV-13.9%33.33710202638.711292026162
PALLETFS Physical Palladium Shares-38.0%23.07710202637.181282026163
USOUnited States Oil Fund LP-28.9%108.707102026152.96519202652
UNGUnited States Natural Gas Fund LP-37.3%10.60710202616.902012026159
BNOUnited States Brent Oil Fund LP ETV-7.1%55.85710202660.13504202667
IBITiShares Bitcoin Trust ETF-34.7%36.23710202655.441142026177
FBTCFidelity Wise Origin Bitcoin Fund-34.7%55.62710202685.121142026177
GBTCGrayscale Bitcoin Trust ETF-19.0%61.84710202676.311142026177
ETHAiShares Ethereum Trust ETF-47.1%13.53710202625.591142026177

ETF Fund Flows

Largest fund inflows and outflows across ETFs, with the asset-allocation rotation they imply.

Net fund flows · as of 2026-07-09

Asset allocation rotation · Past month

  • Equity ETFs drew the largest net inflows (+$66.4B), followed by Bond (+$29.3B), while Commodity (−$3.5B) and Crypto (−$3.0B) saw the largest outflows.
  • Within the mix, money rotated into US Large Cap Core (+$12.6B) and out of Gold (−$3.7B).
  • Relative to fund size, ARKQ drew the largest inflow (+57.3% of AUM) and FXN the largest outflow (−68.9%).
Largest inflows
#TickerNameTypeNet flow% of AUM
1IVViShares Core S&P 500 ETFEquity US Large Cap Core+$56.47B+6.5%
2SPYMState Street SPDR Portfolio S&P 500 ETFEquity US Large Cap Core+$15.25B+10.1%
3DRAMRoundhill Memory ETFOther+$8.81B+38.2%
4LQDiShares iBoxx $ Investment Grade Corporate Bond ETFBond Intermediate Corporate+$6.73B+20.8%
5SOXXiShares Semiconductor ETFEquity Industry Subsector+$6.26B+14.3%
6AVLVAvantis U.S. Large Cap Value ETFOther+$3.75B+22.7%
7VTIVanguard Total Stock Market ETFEquity US Total Market+$3.63B+0.5%
8QQQMInvesco NASDAQ 100 ETFEquity US Nasdaq Growth+$3.61B+3.7%
9VXUSVanguard Total International Stock ETFEquity International Broad+$3.56B+2.3%
10RSPInvesco S&P 500 Equal Weight ETFEquity Factor Smart Beta+$3.25B+3.5%
Largest outflows
#TickerNameTypeNet flow% of AUM
1VOOVanguard S&P 500 ETFEquity US Large Cap Core-$53.22B-5.4%
2SPYState Street SPDR S&P 500 ETFEquity US Large Cap Core-$6.26B-0.8%
3VLUEiShares MSCI USA Value Factor ETFEquity Factor Smart Beta-$4.5B-40.9%
4IAUiShares Gold TrustCommodity Gold-$2.03B-3.3%
5IBITiShares Bitcoin Trust ETFCrypto-$2.0B-4.3%
6GLDSPDR Gold SharesCommodity Gold-$1.38B-1.0%
7VOVanguard Mid-Cap ETFEquity US Mid Cap Core-$1.06B-1.0%
8NASATema Space Innovators ETFEquity Thematic-$872M-53.8%
9FXIiShares China Large-Cap ETFEquity Emerging Markets-$846M-18.2%
10BILState Street SPDR Bloomberg 1-3 Month T-Bill ETFCash-$842M-1.8%

Largest ETF fund flows across ~2562 funds (min AUM $100M). Net creations/redemptions; leveraged & inverse ETFs excluded. A ⚠ marks a day excluded as a suspected data error.

Set Alerts and Notifications

Stay Informed

Trade & Investment Ideas

Wealth

Alert Me Periodically

Inform Me Once

About XBI

0Holdings Count: 157
Expense Ratio: 0.35%
Inception Date: 2006-01-31
State Street SPDR S&P Biotech ETF
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.
Asset Class: Equity | ETF Website

Recent Active Movers

Peer Comparisons

Peers to compare with:

Profile

XBISMHSOXXIBBITAXOPMedian
NameState Stre.VanEck Sem.iShares Se.iShares Bi.iShares U..State Stre. 
Asset ClassEquityEquityEquityEquityEquityEquity-
AUM ($ Bil)10.668.841.09.514.73.012.6
Expense Ratio0.35%0.35%0.34%0.44%0.38%0.35%0.35%
10-D Avg Volume (Mil)8.7810.409.021.470.863.856.32
Latest Day Volume (Mil)7.369.627.911.63-1.517.36
Holdings Count1572630248495150
Inception Date1/31/200612/20/20117/10/20012/5/20015/1/20066/19/2006-

Fundamentals

XBISMHSOXXIBBITAXOPMedian
NameState Stre.VanEck Sem.iShares Se.iShares Bi.iShares U..State Stre. 
Net Asset Value156.50592.26566.67195.79248.59153.75-
Premium/Discount1.6%3.2%2.6%-1.9%-3.8%3.1%2.1%
Distribution Yield0.4%0.2%0.3%0.2%0.0%2.0%0.2%
Sales Yield8.1%6.6%6.5%12.5%28.5%123.0%10.3%
Earnings Yield1.0%1.9%1.6%2.4%2.4%6.4%2.1%

Valuation

XBISMHSOXXIBBITAXOPMedian
NameState Stre.VanEck Sem.iShares Se.iShares Bi.iShares U..State Stre. 
P/S (TTM)12.3x15.2x15.5x8.0x3.5x0.8x10.1x
P/E (TTM)96.6x51.9x63.7x42.2x41.5x15.7x47.0x
P/FCF (TTM)-57.8x69.7x361.0x49.5x24.5x57.8x
Forward P/E68.3x---32.9x9.0x32.9x
Forward P/S9.6x---3.1x0.7x3.1x

Risk

XBISMHSOXXIBBITAXOPMedian
NameState Stre.VanEck Sem.iShares Se.iShares Bi.iShares U..State Stre. 
Volatility (1Y)26.6%36.4%41.7%20.7%22.0%28.0%27.3%
Volatility (3Y)27.5%36.1%38.3%20.3%19.7%27.9%27.7%
Volatility (5Y)32.3%36.1%37.6%22.1%20.2%33.8%33.0%
Beta (1Y)1.042.262.450.811.02-0.151.03
Beta (3Y)1.031.952.030.820.840.700.94
Beta (5Y)1.151.741.790.860.820.881.02
Sharpe Ratio (1Y)2.382.282.301.921.200.892.10
Sharpe Ratio (3Y)0.931.491.290.791.350.471.11
Sharpe Ratio (5Y)0.251.060.930.260.910.520.71
Max Drawdown (1Y)-9.7%-14.9%-15.8%-9.6%-15.8%-18.7%-15.4%
Max Drawdown (3Y)-33.0%-35.7%-41.4%-24.9%-15.8%-35.0%-34.0%
Max Drawdown (5Y)-54.6%-45.3%-45.8%-39.8%-18.7%-35.0%-42.6%

Returns

XBISMHSOXXIBBITAXOPMedian
NameState Stre.VanEck Sem.iShares Se.iShares Bi.iShares U..State Stre. 
1M Return21.0%3.4%3.4%13.4%3.7%-3.3%3.6%
3M Return20.6%42.0%53.5%11.6%3.1%-5.5%16.1%
6M Return25.8%58.7%79.0%8.7%5.7%28.4%27.1%
YTD Return30.4%69.7%93.2%13.9%11.4%26.1%28.3%
1Y Return81.6%114.7%139.1%45.5%27.1%23.5%63.6%
2Y Return74.1%128.3%130.9%41.7%82.6%14.9%78.4%
3Y Return92.6%311.0%255.3%52.4%109.2%31.9%100.9%

Short Interest

Short Interest: As Of Date6152026
Short Interest: Shares Quantity79.1 Mil
Short Interest: % Change Since 53120262.7%
Average Daily Volume8.7 Mil
Days-to-Cover Short Interest9.1 days